AstraZeneca Expands One Deal and Terminates Another
By Helen Scrutton
Pharma Deals Review: Vol 2008 Issue 103 (Table of Contents)
Published: 8 Dec-2008
DOI: 10.3833/pdr.v2008.i103.102 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
AstraZeneca has amended two deals this week as the company determines its R&D investment priorities...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS